Share Twitter LinkedIn Facebook Email Keith McCrae, MD of Cleveland Clinic discusses how patients with HHT disorder respond well to pomalidomide treatment at the 58th ASH Annual Meeting in San Diego, CA.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read